- Report
- January 2026
- 269 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 167 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 264 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 167 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 362 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 173 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 259 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 270 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 263 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 272 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 482 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 462 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 196 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 340 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 177 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- November 2025
- 299 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- October 2025
- 404 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 192 Pages
Global
From €3505EUR$3,939USD£3,044GBP
- Report
- January 2026
- 187 Pages
Global
From €3505EUR$3,939USD£3,044GBP
- Report
- January 2026
- 190 Pages
Global
From €3505EUR$3,939USD£3,044GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more